Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aviva PLC Director's Dealing 2018

Jun 27, 2018

4708_dirs_2018-06-27_c331d649-f998-49b4-bb19-116b1c9d6b31.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8020S

Aviva PLC

27 June 2018

27 June 2018

AVIVA PLC ("Aviva")

NOTIFICATION OF TRANSACTIONS OF DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMRs")

Aviva announces that:

Under the Aviva plc non-executive director share purchase programme (the "programme"), the following non-executive directors of Aviva plc purchased ordinary shares:

Name Total Shares Purchased Purchase Price
Patricia Cross 2,577 £5.05139
Belen Romana-Garcia 828 £5.05139

The programme allows non-executive directors to elect to use a proportion of their net director fees, paid quarterly, to acquire Aviva shares on a continuing basis. Full details of the share purchase are set out below.

This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

Media Enquiries:

Andrew Reid                                                                  +44 (0)207 662 3131

General Enquiries:

Roy Tooley, Company Secretarial                                    +44 (0)207 662 6019

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name PATRICIA CROSS
2 Reason for the notification
a) Position/status NON-EXECUTIVE DIRECTOR
b) Initial notification/Amendment INITIAL NOTIFICATION
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name AVIVA PLC
b) LEI YF0Y5B0IB8SM0ZFG9G81
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
-     SHARES

-     GB0002162385
b) Nature of transaction PURCHASE OF 2,577 AVIVA PLC ORDINARY SHARES
c) Price(s) and volume(s) Price(s) Volume(s)
£5.05139 2,577
d) Aggregated information

-     Aggregated volume

-     Price
-     £5.05139 per share

-     Total Price £13017.44
2,577
e) Date of the transaction 2018-06-25
f) Place of the transaction LONDON STOCK EXCHANGE, XLON
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name BELEN ROMANA-GARCIA
2 Reason for the notification
a) Position/status NON-EXECUTIVE DIRECTOR
b) Initial notification/Amendment INITIAL NOTIFICATION
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name AVIVA PLC
b) LEI YF0Y5B0IB8SM0ZFG9G81
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
-     SHARES

-     GB0002162385
b) Nature of transaction PURCHASE OF 828 AVIVA PLC ORDINARY SHARES
c) Price(s) and volume(s) Price(s) Volume(s)
£5.05139 828
d) Aggregated information

-     Aggregated volume

-     Price
-     £5.05139 per share

-     Total Price £4,182.55
828
e) Date of the transaction 2018-06-25
f) Place of the transaction LONDON STOCK EXCHANGE, XLON

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHXDLFLVQFEBBL